nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—blood vessel—malignant glioma	0.116	0.2	CbGeAlD
Tyloxapol—LPL—embryo—malignant glioma	0.0695	0.12	CbGeAlD
Tyloxapol—LPL—brainstem—malignant glioma	0.0637	0.11	CbGeAlD
Tyloxapol—LPL—retina—malignant glioma	0.0614	0.106	CbGeAlD
Tyloxapol—LPL—telencephalon—malignant glioma	0.0565	0.0972	CbGeAlD
Tyloxapol—LPL—medulla oblongata—malignant glioma	0.0444	0.0764	CbGeAlD
Tyloxapol—LPL—midbrain—malignant glioma	0.0406	0.0698	CbGeAlD
Tyloxapol—LPL—spinal cord—malignant glioma	0.0396	0.0681	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.0326	0.0778	CbGpPWpGaD
Tyloxapol—LPL—central nervous system—malignant glioma	0.0321	0.0553	CbGeAlD
Tyloxapol—LPL—cerebellum—malignant glioma	0.0314	0.054	CbGeAlD
Tyloxapol—LPL—brain—malignant glioma	0.0255	0.0439	CbGeAlD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—CAV1—malignant glioma	0.0128	0.0306	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—NCOR1—malignant glioma	0.0111	0.0265	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.00978	0.0233	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.00946	0.0226	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—malignant glioma	0.00869	0.0208	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—BAD—malignant glioma	0.00835	0.0199	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—malignant glioma	0.00796	0.019	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.00745	0.0178	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NCOR1—malignant glioma	0.00731	0.0175	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.00686	0.0164	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.00671	0.016	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—RTEL1—malignant glioma	0.00643	0.0153	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.00639	0.0152	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.00633	0.0151	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HIF1A—malignant glioma	0.00616	0.0147	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—GDNF—malignant glioma	0.00598	0.0143	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—IL1B—malignant glioma	0.00571	0.0136	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—malignant glioma	0.0057	0.0136	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—malignant glioma	0.00524	0.0125	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00459	0.011	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LATS2—malignant glioma	0.00457	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SOX2—malignant glioma	0.00453	0.0108	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00445	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—malignant glioma	0.00423	0.0101	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—malignant glioma	0.00421	0.01	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—malignant glioma	0.00414	0.00989	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COX8A—malignant glioma	0.00369	0.00882	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—malignant glioma	0.00365	0.00872	CbGpPWpGaD
Tyloxapol—LPL—Disease—BCAN—malignant glioma	0.00352	0.00841	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LATS1—malignant glioma	0.00346	0.00827	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—malignant glioma	0.00344	0.00821	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.0033	0.00788	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—malignant glioma	0.00321	0.00767	CbGpPWpGaD
Tyloxapol—LPL—Disease—DTX1—malignant glioma	0.00319	0.00761	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ASMT—malignant glioma	0.00314	0.0075	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00307	0.00733	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCAN—malignant glioma	0.00295	0.00705	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—malignant glioma	0.00278	0.00664	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PTK2—malignant glioma	0.00257	0.00614	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HES1—malignant glioma	0.00253	0.00603	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCOR1—malignant glioma	0.00251	0.006	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEY2—malignant glioma	0.0025	0.00597	CbGpPWpGaD
Tyloxapol—LPL—Disease—IDH1—malignant glioma	0.00244	0.00583	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—IDH2—malignant glioma	0.00238	0.00568	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDK—malignant glioma	0.00234	0.00559	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEY1—malignant glioma	0.00232	0.00553	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIST1H3B—malignant glioma	0.00225	0.00537	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00224	0.00536	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2B6—malignant glioma	0.00224	0.00534	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DTX1—malignant glioma	0.00223	0.00533	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGFR1—malignant glioma	0.00215	0.00513	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG2—malignant glioma	0.00205	0.0049	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—IDH1—malignant glioma	0.00205	0.00488	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—malignant glioma	0.00202	0.00483	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—malignant glioma	0.00198	0.00473	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SPHK1—malignant glioma	0.00198	0.00473	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2C18—malignant glioma	0.00194	0.00463	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NOTCH1—malignant glioma	0.00191	0.00455	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PTPN11—malignant glioma	0.00183	0.00438	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00183	0.00437	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—malignant glioma	0.0018	0.0043	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SUFU—malignant glioma	0.00177	0.00423	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY2—malignant glioma	0.00175	0.00418	CbGpPWpGaD
Tyloxapol—LPL—Disease—H3F3A—malignant glioma	0.00174	0.00415	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GFAP—malignant glioma	0.00171	0.00408	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT2—malignant glioma	0.00171	0.00407	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00167	0.00398	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPHK1—malignant glioma	0.00166	0.00395	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—malignant glioma	0.00165	0.00395	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG1—malignant glioma	0.00164	0.00391	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR4—malignant glioma	0.00162	0.00387	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY1—malignant glioma	0.00162	0.00387	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00161	0.00384	CbGpPWpGaD
Tyloxapol—LPL—Disease—FBXW7—malignant glioma	0.00161	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIST1H3B—malignant glioma	0.00158	0.00376	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGF2—malignant glioma	0.00157	0.00375	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—malignant glioma	0.00157	0.00375	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—malignant glioma	0.00147	0.00351	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00146	0.0035	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—malignant glioma	0.00146	0.0035	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—malignant glioma	0.00145	0.00346	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG2—malignant glioma	0.00144	0.00343	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCHE—malignant glioma	0.00137	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A5—malignant glioma	0.00135	0.00322	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00128	0.00305	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00126	0.00302	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—malignant glioma	0.00126	0.003	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—malignant glioma	0.00124	0.00297	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H3F3A—malignant glioma	0.00122	0.00291	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR3—malignant glioma	0.00121	0.00288	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—malignant glioma	0.0012	0.00286	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCOR1—malignant glioma	0.00119	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK2—malignant glioma	0.00117	0.0028	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—YWHAE—malignant glioma	0.00117	0.0028	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—malignant glioma	0.00117	0.00279	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DUSP6—malignant glioma	0.00116	0.00277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG1—malignant glioma	0.00115	0.00274	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH3—malignant glioma	0.00114	0.00273	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRA—malignant glioma	0.00114	0.00273	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FBXW7—malignant glioma	0.00112	0.00268	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—malignant glioma	0.00112	0.00266	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—malignant glioma	0.0011	0.00264	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.0011	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BDKRB2—malignant glioma	0.0011	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—malignant glioma	0.00109	0.0026	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAT—malignant glioma	0.00106	0.00253	CbGpPWpGaD
Tyloxapol—LPL—Disease—HLA-A—malignant glioma	0.00105	0.00251	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—malignant glioma	0.00105	0.00251	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFB—malignant glioma	0.00103	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—malignant glioma	0.00102	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR1—malignant glioma	0.00102	0.00244	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—malignant glioma	0.00101	0.0024	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—malignant glioma	0.001	0.0024	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KNG1—malignant glioma	0.001	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOR1—malignant glioma	0.000999	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—malignant glioma	0.000973	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—malignant glioma	0.000956	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK1—malignant glioma	0.000956	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—malignant glioma	0.000948	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Disease—BAD—malignant glioma	0.000915	0.00218	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—malignant glioma	0.000906	0.00216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP3—malignant glioma	0.000889	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD80—malignant glioma	0.000887	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—malignant glioma	0.000886	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—malignant glioma	0.000881	0.0021	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGF—malignant glioma	0.000876	0.00209	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTPN11—malignant glioma	0.00087	0.00208	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTK2—malignant glioma	0.000855	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—malignant glioma	0.00084	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR1—malignant glioma	0.000835	0.00199	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—malignant glioma	0.000833	0.00199	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—malignant glioma	0.000814	0.00194	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—malignant glioma	0.00081	0.00194	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRA—malignant glioma	0.0008	0.00191	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—malignant glioma	0.000779	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000778	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—malignant glioma	0.000777	0.00185	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF2—malignant glioma	0.000746	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—malignant glioma	0.000742	0.00177	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—malignant glioma	0.000736	0.00176	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFB—malignant glioma	0.000719	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—malignant glioma	0.000716	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR1—malignant glioma	0.000715	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—malignant glioma	0.000712	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—malignant glioma	0.000704	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Disease—MDM2—malignant glioma	0.000698	0.00167	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—malignant glioma	0.000695	0.00166	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—malignant glioma	0.000688	0.00164	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—malignant glioma	0.000681	0.00163	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—malignant glioma	0.000679	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—malignant glioma	0.000673	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—malignant glioma	0.000673	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—malignant glioma	0.000652	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—malignant glioma	0.000648	0.00155	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—malignant glioma	0.000648	0.00155	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BAD—malignant glioma	0.000641	0.00153	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—malignant glioma	0.000634	0.00151	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD80—malignant glioma	0.000621	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—malignant glioma	0.00062	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—malignant glioma	0.00062	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGF—malignant glioma	0.000613	0.00146	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN11—malignant glioma	0.000609	0.00146	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—malignant glioma	0.000587	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—malignant glioma	0.000583	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—malignant glioma	0.000568	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—malignant glioma	0.000568	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—malignant glioma	0.000563	0.00134	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—malignant glioma	0.000545	0.0013	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—malignant glioma	0.000525	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF2—malignant glioma	0.000522	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—malignant glioma	0.000491	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDM2—malignant glioma	0.000489	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—malignant glioma	0.000487	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—malignant glioma	0.000487	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—malignant glioma	0.000482	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—malignant glioma	0.000477	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—malignant glioma	0.000475	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—malignant glioma	0.000457	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—malignant glioma	0.00045	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—malignant glioma	0.000437	0.00104	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—malignant glioma	0.000437	0.00104	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—malignant glioma	0.000414	0.000988	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—malignant glioma	0.000413	0.000986	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—malignant glioma	0.000411	0.000981	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—malignant glioma	0.000371	0.000886	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—malignant glioma	0.000367	0.000877	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—malignant glioma	0.000347	0.000827	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—malignant glioma	0.000341	0.000815	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—malignant glioma	0.000338	0.000807	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—malignant glioma	0.000334	0.000797	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—malignant glioma	0.000315	0.000753	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—malignant glioma	0.00029	0.000692	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—malignant glioma	0.000283	0.000676	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—malignant glioma	0.00028	0.000669	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—malignant glioma	0.000237	0.000565	CbGpPWpGaD
